Trial
NCT04213274
Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
R-Pharm Overseas, Inc.
Collaborators
Worldwide Clinical Trials
Condition
Schnitzler Syndrome
Intervention
80 mg RPH-104
Why stopped
due to the decision of company Top management
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-15